Kobayashi Pharmaceutical Weighs Take-Private Proposal From NSSK, CVC Affiliates

Kobayashi Pharmaceutical Co Ltd has disclosed that it received a preliminary, non-binding joint proposal from entities affiliated with NSSK and CVC Capital Partners. The proposal concerns a potential take-private transaction, which the company described as a possible measure to enhance its corporate value.

The disclosure was made in a notice responding to certain media reports about the matter. The Japanese consumer healthcare company said no decision has been taken on the proposal at this stage.

The announcement confirms the approach but leaves the company's position open, with no timeline or further terms indicated. A take-private deal would involve acquiring the listed company's shares and removing it from public markets, though the proposal as described remains at a preliminary and non-binding stage.

Kobayashi Pharmaceutical has not provided additional details on the structure, valuation or conditions attached to the proposal, and it is not yet clear how the company will proceed.